Vancomycin susceptibility as an aid to the identification of lactobacilli

@article{HamiltonMiller1998VancomycinSA,
  title={Vancomycin susceptibility as an aid to the identification of lactobacilli},
  author={Hamilton‐Miller and Shah},
  journal={Letters in Applied Microbiology},
  year={1998},
  volume={26}
}
Forty strains of lactobacilli isolated from probiotic supplements or functional foods, and two clinical isolates, have been identified by API 50 CHL and tested for susceptibility to vancomycin. All the Lactobacillus acidophilus (16) and Lact. delbreuckii (two) strains were sensitive to vancomycin, while all the other strains (mainly Lact. rhamnosus, 15) were resistant. Susceptibility to other antibiotics was not species‐specific. Differential susceptibility to vancomycin may be helpful in… 
6 Citations
Genotypic and phenotypic characterization of food-associated Lactobacillus plantarum isolates for potential probiotic activities.
TLDR
This study highlights analysis of a subset of preliminary important strain specific features to inform isolate comparison and selection for current functional food associations and that can serve as a basis for future strain and food-microbe fermentation product development.
Isolation and characterization of lactic acid bacteria from Chinese human milk.
TLDR
Two novel strains of LAB were obtained that have similar characteristics to the reference strain CECT5716 and are identified as potential probiotic candidates for application in the food and pharmaceutical industries and facilitated identification of further probiotics.
Vancomycin-Induced Modulation of Gram-Positive Gut Bacteria and Metabolites Remediates Insulin Resistance in iNOS Knockout Mice
TLDR
It is demonstrated that vancomycin-mediated depletion of gram-positive bacteria in iNOS−/− mice reversed the metabolic perturbations, dyslipidemia, and insulin resistance.

References

SHOWING 1-4 OF 4 REFERENCES
Clinical manifestations and therapy of Lactobacillus endocarditis: report of a case and review of the literature.
TLDR
High-dose penicillin (greater than 25 million units/day) in combination with an aminoglycoside for a period of six weeks appears to be the optimum therapy.
Modification of peptidoglycan precursors is a DISCUSSION common feature of the low-level vancomycin-resistant VANB
  • 1994
Lactic acid bacteria and terminus of the peptidoglycan MurNAc peptide. human clinical infection
  • Journal of Applied Bacteriology
  • 1993
Clinical and . micro - with vancomycin can add considerable value to the results biologic characteristics of pediococci
  • 1990